Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19 : L'entraînement Olfactif Comme Traitement de la Dysfonction Olfactive Post COVID-19
Olfactory dysfunction is a defining symptom of COVID-19 infection. Studies have demonstrated improved olfaction in patients with post infectious olfactory dysfunction after an olfactory training (OT). The aim of this study is to assess the clinical outcomes of olfactory training (12 weeks) therapy in the treatment of persistent olfactory dysfunctions after COVID-19. Specially, we aim to compare the effectiveness of two different olfactory training (different odors) with a placebo group.A group will train themselves with 4 scents (rose, orange, clove and eucalyptus) and another group with 4 different scents (cheese, coffee, strawberries and lemon). The placebo group will train themselves with an odorless substance. Olfaction sensory evaluation will be performed by using different olfaction tests (Sniffin' Sticks and UPSIT) and complete questionnaires to assess olfactory perception and particularly parosmia and phantosmia..
| Medienart: |
|
|---|
Klinische Studie| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
ClinicalTrials.gov - (2022) vom: 26. Mai Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
610 |
|---|
| Anmerkungen: |
Source: Link to the current ClinicalTrials.gov record., First posted: May 20, 2022, Last downloaded: ClinicalTrials.gov processed this data on May 30, 2022, Last updated: June 01, 2022 |
|---|
| Study ID: |
NCT05384561 |
|---|---|
| Veröffentlichungen zur Studie: |
|
| fisyears: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
CTG008467927 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | CTG008467927 | ||
| 003 | DE-627 | ||
| 005 | 20230425215535.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220525s2022 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)CTG008467927 | ||
| 035 | |a (UBBS_Klinische_Studien)NCT05384561 | ||
| 035 | |a (UBBS_Klinische_Studien)OTTODC192022JFUQTR | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19 |b L'entraînement Olfactif Comme Traitement de la Dysfonction Olfactive Post COVID-19 |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: Link to the current ClinicalTrials.gov record., First posted: May 20, 2022, Last downloaded: ClinicalTrials.gov processed this data on May 30, 2022, Last updated: June 01, 2022 | ||
| 520 | |a Olfactory dysfunction is a defining symptom of COVID-19 infection. Studies have demonstrated improved olfaction in patients with post infectious olfactory dysfunction after an olfactory training (OT). The aim of this study is to assess the clinical outcomes of olfactory training (12 weeks) therapy in the treatment of persistent olfactory dysfunctions after COVID-19. Specially, we aim to compare the effectiveness of two different olfactory training (different odors) with a placebo group.A group will train themselves with 4 scents (rose, orange, clove and eucalyptus) and another group with 4 different scents (cheese, coffee, strawberries and lemon). The placebo group will train themselves with an odorless substance. Olfaction sensory evaluation will be performed by using different olfaction tests (Sniffin' Sticks and UPSIT) and complete questionnaires to assess olfactory perception and particularly parosmia and phantosmia. | ||
| 650 | 2 | |a COVID-19 | |
| 650 | 2 | |a Anosmia | |
| 650 | 2 | |a Olfaction Disorders | |
| 650 | 4 | |a Medical Condition: Hyposmia, COVID-19, Parosmia, Anosmia, SARS-CoV-2 Infection | |
| 650 | 4 | |a Study Type: Interventional | |
| 650 | 4 | |a Recruitment Status: Recruiting | |
| 650 | 4 | |a 610 | |
| 773 | 0 | 8 | |i Enthalten in |t ClinicalTrials.gov |g (2022) vom: 26. Mai |
| 773 | 1 | 8 | |g year:2022 |g day:26 |g month:05 |
| 856 | 4 | 0 | |u https://clinicaltrials.gov/show/NCT05384561 |z kostenfrei |3 Volltext |
| 912 | |a GBV_CTG | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 26 |c 05 | ||